ISG15 Is Counteracted by Vaccinia Virus E3 Protein and Controls the Proinflammatory Response against Viral Infection

ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection

(2013) Emilio Yángüez et al.   PLoS Pathogens

Mycobacterial Disease and Impaired IFN-  Immunity in Humans with Inherited ISG15 Deficiency

(2012) D. Bogunovic et al.   SCIENCE

Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein

(2011) Susana Guerra et al.   PLoS One

ISG15 Is Critical in the Control of Chikungunya Virus Infection Independent of UbE1L Mediated Conjugation

(2011) Scott W. Werneke et al.   PLoS Pathogens

Emerging Role of ISG15 in Antiviral Immunity

(2010) Brian Skaug et al.   CELL

Species Specificity of the NS1 Protein of Influenza B Virus

(2010) Haripriya Sridharan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Species-Specific Antagonism of Host ISGylation by the Influenza B Virus NS1 Protein

(2010) G. A. Versteeg et al.   JOURNAL OF VIROLOGY

Antiviral Properties of ISG15

(2010) Deborah J. Lenschow   Viruses-Basel

Regulation of the Nuclear Factor (NF)-κB Pathway by ISGylation

(2008) Miki Minakawa et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

ISG15 Inhibits Nedd4 Ubiquitin E3 Activity and Enhances the Innate Antiviral Response

(2008) Oxana A. Malakhova et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity

(2008) A. Okumura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vaccinia Virus E3 Protein Prevents the Antiviral Action of ISG15

(2008) Susana Guerra et al.   PLoS Pathogens